1
Hiroitsu Kawata, Masayoshi Aruga, Tadayoshi Ohmura, Takashi Sonobe, Satoru Yoneya, Chiharu Sone: Sustained release pharmaceutical composition of solid medical material. Yamanouchi Pharmaceutical, Burgess Ryan & Wayne, September 13, 1983: US04404183 (109 worldwide citation)

Sustained release pharmaceutical compositions of a solid medical material which contains an amorphous solid medical material, polyethylene oxide, and at least one basic substance selected from the group consisting of hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methyl cellulose, polyvinyl ...


2
Hiroitsu Kawata, Masayoshi Aruga, Tadayoshi Ohmura, Takashi Sonobe, Satoru Yoneya, Chiharu Sone: Sustained release pharmaceutical composition of solid medical material. Yamanouchi Pharmaceutical, Burgess Ryan and Wayne, August 10, 1982: US04343789 (102 worldwide citation)

Sustained release pharmaceutical composition of a solid medical material which contains an amorphous solid medical material, polyethylene oxide, and at least one basic substance selected from the group consisting of hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methyl cellulose, polyvinyl ...


3
Yutaka Konno, Hiroitsu Kawata, Masayoshi Aruga, Takashi Sonobe, Mitsuo Mitomi: Patch. Yamanouchi Pharmaceutical, Burgess Ryan & Wayne, August 11, 1987: US04685911 (76 worldwide citation)

A patch having good transdermal property which utilizes a suppository base e.g. triglyceride of a vegetable saturated fatty acid having 12 to 18 carbon atoms together with a penetration enhancer.


4
Hiroitsu Kawata, Masayoshi Aruga, Tadayoshi Ohmura, Takashi Sonobe, Satoru Yoneya, Chiharu Sone: Sustained release pharmaceutical composition of solid medical material. Yamanouchi Pharmaceutical, Burgess Ryan & Wayne, June 16, 1987: US04673564 (49 worldwide citation)

Sustained release pharmaceutical compositions of a solid medical material which contains an amorphous solid medical material, polyethylene oxide, and at least one basic substance selected from the group consisting of hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methyl cellulose, polyvinyl ...


5
Muneo Fukui, Yutaka Konno, Yukio Kubota, Masayoshi Aruga, Hiroitsu Kawata: Solid drug preparations. Yamanouchi Pharmaceutical, Burgess Ryan and Wayne, April 19, 1983: US04380534 (38 worldwide citation)

A solid microdose drug preparation containing a microdose drug such as formoterol fumarate or .beta.-methyldigoxin coated with wax.


6
Muneo Fukui, Kouji Tomuro, Shigeru Masuyama, Atsushi Kajiyama, Tamio Hikosaka, Masayoshi Aruga, Saburo Higuchi, Yoshiaki Soeishi: Controlled-release multiple units pharmaceutical formulation. Yamanouchi Pharmaceutical, Burgess Ryan and Wayne, September 20, 1988: US04772475 (35 worldwide citation)

A pharmaceutical controlled-release individual unit or multiple units formulation in which the individual unit comprises a granulation product obtained by adding a release controlling agent to a mixture of a physiologically active substance and units-forming substance(s) and granulating and resultan ...


7
Seiya Kagatani, Shunji Hasumi, Takashi Sonobe, Masayoshi Aruga: Pharmaceutical compositions for nasal administration comprising calcitonin and an absorption-promoting substance. Yamanouchi Pharmaceutical Co, Burgess Ryan and Wayne, September 1, 1987: US04690952 (33 worldwide citation)

Pharmaceutical compositions for intranasal administration comprising (a) calcitonin and (b) at least one absorption enhancer selected from the group consisting of benzyl alcohol, ethanol, thiamine or a salt thereof, salicylic acid or a salt thereof, capric acid or a salt thereof, Macrogol 400, pyrid ...


8
Yutaka Konno, Hiroitsu Kawata, Masayoshi Aruga, Takashi Sonobe, Mitsuo Mitomi: Patch. Yamanouchi Pharmaceutical, Burgess Ryan & Wayne, November 7, 1989: US04879119 (29 worldwide citation)

A patch having good transdermal property which utilizes a suppository base e.g. triglyceride of a vegetable saturated fatty acid having 12 to 18 carbon atoms together with a penetration enhancer.


9
Yutaka Konno, Hiroitsu Kawata, Masayoshi Aruga, Takashi Sonobe, Mitsuo Mitomi: Transdermal formulation of nicardipine hydrochloride. Yamanouchi Pharmaceutical, Burgess Ryan & Wayne, January 20, 1987: US04637930 (21 worldwide citation)

A formulation is provided for the transdermal administration of nicardipine hydrochloride. The formulation is comprised of nicardipine hydrochloride dissolved or suspended in a mixed liquid composed of an urea and at least one compound selected from the group consisting of propylene glycol, a monohy ...


10
Seiya Kagatani, Shunji Hasumi, Takashi Sonobe, Masayoshi Aruga: Pharmaceutical compositions comprising calcitonin and an absorption-promoting substance. Yamanouchi Pharmaceutical, Burgess Ryan & Wayne, November 29, 1988: US04788221 (17 worldwide citation)

Pharmaceutical compositions for intranasal administration comprising (a) calcitonin and (b) at least one absorption enhancer selected from the group consisting of benzyl alcohol, ethanol, thiamine or a salt thereof, salicylic acid or a salt thereof, capric acid or a salt thereof, Macrogol 400, pyrid ...



Click the thumbnails below to visualize the patent trend.